#begin document (wsj_1904.en); part 000
wsj_1904.en	0	0	Britain	(4
wsj_1904.en	0	1	's	-
wsj_1904.en	0	2	Monopolies	-
wsj_1904.en	0	3	and	-
wsj_1904.en	0	4	Mergers	-
wsj_1904.en	0	5	Commission	4)
wsj_1904.en	0	6	Wednesday	-
wsj_1904.en	0	7	cleared	-
wsj_1904.en	0	8	Rhone-Poulenc	(1|(2
wsj_1904.en	0	9	S.A.	-
wsj_1904.en	0	10	's	1)
wsj_1904.en	0	11	purchase	-
wsj_1904.en	0	12	of	-
wsj_1904.en	0	13	a	-
wsj_1904.en	0	14	specialty	-
wsj_1904.en	0	15	bulk-chemical	-
wsj_1904.en	0	16	unit	-
wsj_1904.en	0	17	from	-
wsj_1904.en	0	18	Monsanto	(3
wsj_1904.en	0	19	Co.	2)|3)
wsj_1904.en	0	20	,	-
wsj_1904.en	0	21	saying	-
wsj_1904.en	0	22	the	(2
wsj_1904.en	0	23	purchase	2)
wsj_1904.en	0	24	was	-
wsj_1904.en	0	25	unlikely	-
wsj_1904.en	0	26	to	-
wsj_1904.en	0	27	have	-
wsj_1904.en	0	28	any	-
wsj_1904.en	0	29	lasting	-
wsj_1904.en	0	30	impact	-
wsj_1904.en	0	31	on	-
wsj_1904.en	0	32	U.K.	-
wsj_1904.en	0	33	industrial	-
wsj_1904.en	0	34	consumers	-
wsj_1904.en	0	35	.	-

wsj_1904.en	0	0	The	(4
wsj_1904.en	0	1	commission	4)
wsj_1904.en	0	2	,	-
wsj_1904.en	0	3	which	(4)
wsj_1904.en	0	4	was	-
wsj_1904.en	0	5	asked	-
wsj_1904.en	0	6	to	-
wsj_1904.en	0	7	study	-
wsj_1904.en	0	8	the	(2
wsj_1904.en	0	9	deal	2)
wsj_1904.en	0	10	by	-
wsj_1904.en	0	11	the	-
wsj_1904.en	0	12	Department	-
wsj_1904.en	0	13	of	-
wsj_1904.en	0	14	Trade	-
wsj_1904.en	0	15	and	-
wsj_1904.en	0	16	Industry	-
wsj_1904.en	0	17	after	-
wsj_1904.en	0	18	its	(2)
wsj_1904.en	0	19	announcement	-
wsj_1904.en	0	20	in	-
wsj_1904.en	0	21	February	-
wsj_1904.en	0	22	,	-
wsj_1904.en	0	23	said	-
wsj_1904.en	0	24	the	(5
wsj_1904.en	0	25	diversity	-
wsj_1904.en	0	26	of	-
wsj_1904.en	0	27	global	-
wsj_1904.en	0	28	supply	-
wsj_1904.en	0	29	of	-
wsj_1904.en	0	30	chemicals	(6)
wsj_1904.en	0	31	used	-
wsj_1904.en	0	32	in	-
wsj_1904.en	0	33	making	-
wsj_1904.en	0	34	analgesic	-
wsj_1904.en	0	35	drugs	5)
wsj_1904.en	0	36	was	-
wsj_1904.en	0	37	great	-
wsj_1904.en	0	38	enough	-
wsj_1904.en	0	39	to	-
wsj_1904.en	0	40	offset	-
wsj_1904.en	0	41	the	(7
wsj_1904.en	0	42	dominant	-
wsj_1904.en	0	43	U.K.	-
wsj_1904.en	0	44	market	-
wsj_1904.en	0	45	share	7)
wsj_1904.en	0	46	Rhone-Poulenc	(1)
wsj_1904.en	0	47	would	-
wsj_1904.en	0	48	gain	-
wsj_1904.en	0	49	through	-
wsj_1904.en	0	50	the	(2
wsj_1904.en	0	51	acquisition	2)
wsj_1904.en	0	52	.	-

wsj_1904.en	0	0	The	(1
wsj_1904.en	0	1	French	-
wsj_1904.en	0	2	chemical	-
wsj_1904.en	0	3	giant	1)
wsj_1904.en	0	4	would	-
wsj_1904.en	0	5	hold	-
wsj_1904.en	0	6	an	-
wsj_1904.en	0	7	80	-
wsj_1904.en	0	8	%	-
wsj_1904.en	0	9	share	-
wsj_1904.en	0	10	of	-
wsj_1904.en	0	11	the	-
wsj_1904.en	0	12	U.K.	-
wsj_1904.en	0	13	market	-
wsj_1904.en	0	14	for	-
wsj_1904.en	0	15	salicylic	-
wsj_1904.en	0	16	acid	-
wsj_1904.en	0	17	,	-
wsj_1904.en	0	18	methyl	-
wsj_1904.en	0	19	salicylate	-
wsj_1904.en	0	20	and	-
wsj_1904.en	0	21	bulk	-
wsj_1904.en	0	22	aspirin	-
wsj_1904.en	0	23	.	-

wsj_1904.en	0	0	The	(4
wsj_1904.en	0	1	commission	4)
wsj_1904.en	0	2	found	-
wsj_1904.en	0	3	that	-
wsj_1904.en	0	4	if	-
wsj_1904.en	0	5	the	(9|(11
wsj_1904.en	0	6	British	-
wsj_1904.en	0	7	government	9)
wsj_1904.en	0	8	attempted	-
wsj_1904.en	0	9	to	-
wsj_1904.en	0	10	block	-
wsj_1904.en	0	11	the	(2
wsj_1904.en	0	12	merger	2)|11)
wsj_1904.en	0	13	,	-
wsj_1904.en	0	14	Rhone-Poulenc	(1)
wsj_1904.en	0	15	would	-
wsj_1904.en	0	16	likely	-
wsj_1904.en	0	17	respond	-
wsj_1904.en	0	18	by	-
wsj_1904.en	0	19	closing	-
wsj_1904.en	0	20	the	(10
wsj_1904.en	0	21	salicylates	-
wsj_1904.en	0	22	plant	10)
wsj_1904.en	0	23	Monsanto	(3)
wsj_1904.en	0	24	operates	-
wsj_1904.en	0	25	in	-
wsj_1904.en	0	26	Wales	-
wsj_1904.en	0	27	,	-
wsj_1904.en	0	28	removing	-
wsj_1904.en	0	29	the	-
wsj_1904.en	0	30	matter	-
wsj_1904.en	0	31	from	-
wsj_1904.en	0	32	U.K.	-
wsj_1904.en	0	33	jurisdiction	-
wsj_1904.en	0	34	.	-

#end document 